SaHF DMBC Volume 1 Edition 1.1.pdf - Shaping a healthier future

local clinicians involved in the programme can be found in Appendix A. Additionally
engagement has taken place with wider groups of local clinicians, such as at four
public and clinical engagement events (further information in Appendices B and C).
Engagement with clinicians has always been led by the senior clinicians involved in
the programme
Informed by engagement with the public, patients and local authorities:
Engagement has taken place with local stakeholders at each stage of development
to understand the potential impact of any proposals; including direct involvement of
NW London‟s Patient and Public Advisory Group (PPAG) and engaging with the
Health and Wellbeing Boards, and the Joint Health Overview and Scrutiny
Committee. The four Medical Directors have been actively involved in a wide variety
of engagement events across all the different stakeholder groups identified. Further
information on stakeholder engagement undertaken can be found in Section 3.5 and
in Appendix B. We undertook formal public consultation, for 14 weeks, during which
we explained our proposals, and how they have been developed, to the wider public
and listened to their views on the implications of those proposals. Recent guidance
from the Cabinet Office is that anything from two to 12 weeks is sufficient – we
consulted over 14 weeks so we have gone further than these guidelines suggest. We
believe that 14 weeks was plenty of time for people to consider our proposals and fill
in a response form, even allowing for summer holidays and other events which took
place this summer. This included specific work to understand the implication of
proposals on different groups, in particular the nine protected groups defined under
the Equality Act 2010 including those communities who are believed to be hardest to
reach. Further information on the findings and subsequent responses to the public
consultation can be found in Chapter 6
Robust and transparent process underpinned by a sound clinical evidence
base: Our Case for Change and quality standards are already based on sound local
and national clinical evidence (details of the clinical evidence base are in Chapter 11,
Appendices D and E). We have used a robust, evidence-based process for
developing and appraising options for change that we have shared with stakeholders
at each stage of its development; working in particular with senior local clinicians and
external clinical advisors to ensure any options are clinically sound. This has also
included discussing the impact of proposals with staff (including meetings in all of the
hospitals in NW London), patients and the public – for residents of each borough, for
addressing inequalities, for patients with specific healthcare needs and on patient
travel times – and considering impacts on activity, capacity at different sites, and
financial and capital implications for providers and commissioners
Consistency with current and prospective patient choice: The core principles of
centralising, localising and integrating will have an impact on the way services are
provided, and therefore on the choices available to the public. These three concepts
are described in Chapter 7 as part of our vision for care. We believe this impact will
be positive and will provide a choice of higher quality services in NW London. We
continue to work with local clinicians, our PPAG and Overview and Scrutiny
Committees to consider how our proposal for service change may affect other
aspects of patient choice (i.e. choice of provider, setting and intervention) as
described in the NHS Constitution.
We have sought views from patients, their representatives and other local stakeholders as
this work has developed and will continue to do so during implementation of the changes
once agreed.
3. Introduction to Shaping a healthier future and purpose of document 14